Skip to main content
. 2020 Apr 9;12(4):337. doi: 10.3390/pharmaceutics12040337

Table 3.

Hot-melt extrusion process parameters for the drug-containing amorphous solid dispersions (ASDs) including drug content.

Composition HME Conditions Content (Assay)
(%)
Temperature
(°C)
Feed Rate
(%)
Torque
(%)
IND/PEG3000/PVAP
10/10/80
120 1 49.3 99.5 ± 3.21
120 2 60.0 99.3 ± 1.13
120 3 66.7 104.2 ± 0.04
DPD/PEG3000/PVAP
10/10/80
120 1 50.0 0.85 ± 0.01
120 2 56.6 4.3 ± 0.01
120 3 66.7 7.5 ± 0.12